Skip to main content
Clinical Trials/JPRN-UMIN000005647
JPRN-UMIN000005647CompletedPhase 2

A prospectve study to evaluate the efficacy of pregabalin for chemotherapy-induced peripheral nueralgia - Pregabaalin for chemotherapy-induced peripheral nueralgia

Tokyo University, Dep. of Hematology and Oncology0 sites50 target enrollmentStarted: June 1, 2011Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1. decreased renal function (creatinine clearance equal to 60mL/min or less) 2. ocular disturbances including vision abnoramlity 3. underlying diabetes mellitus or postherpetic neuralgia 4. with previous history of pregabalin administration

Investigators

Sponsor
Tokyo University, Dep. of Hematology and Oncology

Similar Trials